Skip to main content

Table 1 The relationship of lncRNA OTUD6B-AS1 expression levels (-ΔCt) in cancer tissue with clinical features in KIRC patients

From: Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway

Variable KIRC Group χ2 p-Value
Low lncRNA High lncRNA
Sample (n) 52 26 26  
 Median circ -
-
−6.0999141
(− 0.169--10.594333)
 
Median age (year) 56.8(35–82) 0.693 0.405
≤ 56 27(51.9%) 12 15
> 56 25(48.1%) 14 11
Gender 0.080 0.777
 Male 31(59.6%) 15 16
 Female 21(40.4%) 11 10
Clinical stage 5.026 0.025*
 Stage I+ II 36(69.2%) 12 24
 Stage III+ IV 16(38.8%) 14 2
Tumor stage 13.000 0.000*
 T1+ T2 39(75.0%) 16 23
 T3+ T4 13(25.5%) 10 3
Lymph node metastasis 4.591 0.032*
 N0 37(71.6%) 15 22
 N1 15(28.4%) 11 4
 NX
Distant metastasis 4.127 0.042*
 M0 45(86.5%) 20 25
 M1 7(13.5%) 6 1
 MX
Staus 0.002*
 Dead 25(48.1%) 17 6 9.433
 Alive 27(51.9) 9 20  
  1. Low/high by the sample mean. Pearson χ2-test. p < 0.05 was considered statistically significant